Herein, treatment with cabozantinib, with potent activity against VEGFR2, induced a significant reduction in R2* in hypervascular tumours arising in Th-MYCN mice, and this was associated with a significant reduction in microvessel density and VEGFR2 expression, consistent with anti-angiogenic activity. Here, KDR is linked to neoplasm.